SAN DIEGO, March 17, 2026 /PRNewswire/ -- VST BIO Corporation ("VST BIO"), a biotechnology company developing stroke therapeutics, announces the closing of its Series A financing, led by Coefficient ...
Looking at the universe of stocks we cover at Dividend Channel, on 2/14/25, Cencora Inc (Symbol: COR), Bio-Techne Corp (Symbol: TECH), and Eli Lilly (Symbol: LLY) will all trade ex-dividend for their ...
Bio-Techne Corporation (NASDAQ:TECH) is one of the most profitable biotech stocks to invest in now. On July 9, TD Cowen analyst Daniel Brennan initiated a new Buy rating on Bio-Techne Corporation ...
MINNEAPOLIS--(BUSINESS WIRE)--Humanetics Corporation (Humanetics) announced today that BIO 300, a drug under development to increase survival in persons exposed to high levels of radiation, has been ...
Bio-Techne Corporation has been a long term value creator, combining organic growth with sound M&A deals. This has resulted in long-term value creation, as Bio-Techne Corporation shares have looked ...
With its stock down 6.6% over the past month, it is easy to disregard Bio-Techne (NASDAQ:TECH). However, stock prices are usually driven by a company’s financials over the long term, which in this ...
Bio-Techne introduces a streamlined brand architecture that organizes its technologies into three focused portfolio brands: R&D Systems, Bio-Techne Spatial, and Bio-Techne Diagnostics.The new ...
The MarketWatch News Department was not involved in the creation of this content. SAN DIEGO, March 17, 2026 /PRNewswire/ -- VST BIO Corporation ("VST BIO"), a biotechnology company developing stroke ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results